Project partners

KTH Royal Institute of Technology

KTH Royal Institute of Technology

Kungliga Tekniska Högskolan (Royal Institute of Technology), KTH, was founded in 1827 and is the largest technical university in Scandinavia. The university is responsible for one-third of Sweden’s capacity for engineering studies and technical research at post-secondary level. The university has over 12,000 undergraduate students, 1,400 active postgraduate students and a staff of 3,100 people. KTH conducts education and research of a broad spectrum - from natural science to all branches of technology, including architecture, industrial economics, urban planning, work science and environmental technology. Apart from research performed at the departments, a large number of national Centres of Excellence are located at KTH.
The School of Biotechnology consists of 9 different departments with approximately 210 researchers. The Department of Proteomics headed by Professor Mathias Uhlén is involved in the work of the BIO-NMD project and conducts research within the field of antibody-based proteomics with focus on development of high throughput methods and use of the methodology for biomarker discovery and system biology.
 

 KTH's website

Contact: Cristina Al-Khalili Szigyarto
Email Cristina

KTH Biotechnology
AlbaNova University Center
Royal Institute of Technology (KTH)
106 91 Stockholm
Sweden

 

KTH and BIO-NMD

The Royal Institute of Technology (KTH) is involved with WP4 - Exploratory biomarkers validation in humans.

 

Cristina Al-Khalili Szigyarto



Cristina Al-Khalili Szigyarto is a senior researcher at the Royal Institute of Technology (KTH), School of Biotechnology, Stockholm, Sweden coordinating the Human Protein Atlas collaborative projects and working with external relations. The focus of her research activities concerns application of bioinformatic tools and antibody-based proteomics methods for characterization of human proteins in particular biomarker candidates. She has during past years been involved in developing new strategies for selection of antigens as well as cross-/validation of antibodies on different application platforms.

 

Mathias Uhlen



Mathias Uhlen is Professor of Microbiology at the Royal Institute of Technology (KTH), School of Biotechnology, Stockholm, Sweden and manager of Sweden’s largest initiative - the Science for Life Laboratory. He is also currently leading the Human Protein Atlas Project (HPA), with the aim to systematically map the human proteome. Together with his group Mathias Uhlén aims to published characterization all human proteins via the Human Protein Atlas  web site (www.proteinatlas.org) showing distribution of proteins in 48 different normal tissues, 20 different cancer types and  47 different human cell lines as well as cellular localization of proteins in 3 cell lines. His research interests include high-throughput proteomics, development of affinity-based proteomics methods and their application in systems biology and medicine. In his previous work he has developed new affinity reagents as well as investigated the potential of using them as tools for diagnostic and therapeutic purposes. He has published more than 300 publications in bioscience with the focus on the development and use of affinity reagents for both basic and applied research. Dr Uhlen is member of the Royal Swedish Academy of Engineering Science (IVA), the Royal Swedish Academy of Science (KVA), the European Molecular Biology Organization (EMBO) and member of the Human Proteome Organization (HUPO) council. He was Vice-President of the Royal Institute of Technology (KTH), responsible for external relations, from 1999 to 2001. He was the chairman of the Swedish Biochemical and Molecular Biology Society (SFMB) from 1994 to 1999.

 
 




FP7 & EU flag